Your browser doesn't support javascript.
loading
effects of low dose intravenous immunoglobulin on the outcome of Guillian Barre syndrome
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 1996; 6 (1): 55-57
en Inglés | IMEMR | ID: emr-95940
ABSTRACT
Twenty-two patients with Guillian Barre Syndrome admitted to the Department of Neurology, Pakistan Institute of Medical Sciences [PIMS] between November 1993 and March 1995 were given five grams of intravenous immunologlobulin daily for five days. Fourteen patients were male and 8 female. The duration of symptoms before the start of treatment was one to ten days. Fifty per cent of patients had no history of antecedent illness, while seven [31.82%] had diarrhoea and 3 [13.64%] had upper respiratory infection up to 2 weeks prior to the onset of GBS. Improvement was assessed on days 7 and 14, and 4 weeks after start of treatment. Fifteen patients [68.18%] had grade 0-1 power at the start of the treatment. After one month of follow-up all patients had grade 2 power or more. Fifteen [68.18%] had grade 4 and 5 power. Two patients died. This preliminary trial of low dose immunoglobulin indicates its effectiveness in GBS
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Heparina / Inmunoglobulinas Intravenosas / Administración Intravenosa / Antibacterianos Idioma: Inglés Revista: J. Coll. Physicians Surg. Pak. Año: 1996

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Heparina / Inmunoglobulinas Intravenosas / Administración Intravenosa / Antibacterianos Idioma: Inglés Revista: J. Coll. Physicians Surg. Pak. Año: 1996